DCAF7 Antikörper (N-Term)

Produktnummer ABIN928603

Produktdetails anti-DCAF7 Antikörper

Target: DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))

Bindungsspezifität: N-Term

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser DCAF7 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Kreuzreaktivität: Maus

Aufreinigung: Purified

Immunogen: Dcaf7 antibody was raised in rabbit using the N terminal of Dcaf7 as the immunogen

Anwendungsinformationen

Applikationshinweise: Optimal conditions should be determined by the investigator.

Kommentare:

Dcaf7 Blocking Peptide, catalog no. 33R-8588, is also available for use as a blocking control in assays to test for specificity of this Dcaf7 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu DCAF7

Target: DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))

Andere Bezeichnung: Dcaf7 (DCAF7 Produkte)

Hintergrund: Dcaf7 is involved in craniofacial development. It acts upstream of the EDN1 pathway and is required for formation of the upper jaw equivalent, the palatoquadrate. The activity required for EDN1 pathway function differs between the first and second arches. It associates with DIAPH1 and controls GLI1 transcriptional activity. It could be involved in skin development. It may function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. Synonyms: Polyclonal Dcaf7 antibody, Anti-Dcaf7 antibody, DDB1 and CUL4 associated factor 7 antibody, 1700012F10Rik antibody, 2610037L01Rik antibody, C86529 antibody, HAN11 antibody, Wdr68 antibody.

Pathways: SARS-CoV-2 Protein Interaktom